Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Gpr85 | Rat | (2,4,5-trichlorophenoxy)acetic acid | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18579281 | Gpr85 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Gpr85 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GPR85 mRNA | CTD | PMID:22206623 | Gpr85 | Rat | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of GPR85 mRNA | CTD | PMID:17351261 | Gpr85 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gpr85 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPR85 mRNA | CTD | PMID:21570461 | Gpr85 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPR85 mRNA | CTD | PMID:33387578 | Gpr85 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Gpr85 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of GPR85 mRNA | CTD | PMID:18648102 | Gpr85 | Rat | acrylamide | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of GPR85 mRNA | CTD | PMID:32763439 | Gpr85 | Rat | aflatoxin B1 | decreases methylation | ISO | GPR85 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GPR85 gene | CTD | PMID:27153756 | Gpr85 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA | CTD | PMID:37567420 | Gpr85 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GPR85 mRNA | CTD | PMID:16483693 | Gpr85 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of GPR85 mRNA | CTD | PMID:30779732 | Gpr85 | Rat | antirheumatic drug | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GPR85 mRNA | CTD | PMID:24449571 | Gpr85 | Rat | benzo[a]pyrene | affects methylation | ISO | GPR85 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPR85 5' UTR and Benzo(a)pyrene affects the methylation of GPR85 promoter | CTD | PMID:27901495 | Gpr85 | Rat | benzo[a]pyrene | increases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GPR85 mRNA | CTD | PMID:32234424 | Gpr85 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPR85 mRNA | CTD | PMID:25181051 | Gpr85 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GPR85 mRNA | CTD | PMID:30816183 more ... | Gpr85 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of GPR85 mRNA | CTD | PMID:33453195 | Gpr85 | Rat | casticin | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | casticin results in decreased expression of GPR85 mRNA | CTD | PMID:28444820 | Gpr85 | Rat | chloroethene | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Vinyl Chloride results in decreased expression of GPR85 mRNA | CTD | PMID:18579281 | Gpr85 | Rat | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of GPR85 mRNA | CTD | PMID:18668222 | Gpr85 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of GPR85 mRNA | CTD | PMID:30556269 | Gpr85 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of GPR85 mRNA | CTD | PMID:30556269 | Gpr85 | Rat | copper(II) sulfate | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Copper Sulfate results in decreased expression of GPR85 mRNA | CTD | PMID:18579281 | Gpr85 | Rat | D-glucose | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA | CTD | PMID:37567420 | Gpr85 | Rat | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of GPR85 mRNA | CTD | PMID:23640034 | Gpr85 | Rat | decabromodiphenyl ether | multiple interactions | EXP | | 6480464 | [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of GPR85 mRNA | CTD | PMID:32207525 | Gpr85 | Rat | dextran sulfate | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR85 mRNA | CTD | PMID:29950665 | Gpr85 | Rat | dorsomorphin | multiple interactions | ISO | GPR85 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR85 mRNA | CTD | PMID:27188386 | Gpr85 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of GPR85 mRNA | CTD | PMID:29391264 | Gpr85 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of GPR85 mRNA | CTD | PMID:30307764 | Gpr85 | Rat | fructose | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA | CTD | PMID:37567420 | Gpr85 | Rat | glucose | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA | CTD | PMID:37567420 | Gpr85 | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of GPR85 mRNA | CTD | PMID:20080153 | Gpr85 | Rat | methylmercury chloride | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GPR85 mRNA | CTD | PMID:28001369 | Gpr85 | Rat | monosodium L-glutamate | increases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of GPR85 mRNA | CTD | PMID:22078008 | Gpr85 | Rat | ozone | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GPR85 mRNA | CTD | PMID:34911549 | Gpr85 | Rat | paracetamol | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GPR85 mRNA | CTD | PMID:26690555 | Gpr85 | Rat | pravastatin | increases expression | EXP | | 6480464 | Pravastatin results in increased expression of GPR85 mRNA | CTD | PMID:27225895 | Gpr85 | Rat | pravastatin | increases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Pravastatin results in increased expression of GPR85 mRNA | CTD | PMID:27225895 | Gpr85 | Rat | SB 431542 | multiple interactions | ISO | GPR85 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR85 mRNA | CTD | PMID:27188386 | Gpr85 | Rat | serpentine asbestos | increases methylation | ISO | GPR85 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in increased methylation of GPR85 5' UTR | CTD | PMID:29523930 | Gpr85 | Rat | silver atom | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Silver results in decreased expression of GPR85 mRNA | CTD | PMID:27131904 | Gpr85 | Rat | silver(0) | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Silver results in decreased expression of GPR85 mRNA | CTD | PMID:27131904 | Gpr85 | Rat | succimer | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR85 mRNA | CTD | PMID:21641980 | Gpr85 | Rat | sulforaphane | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of GPR85 mRNA | CTD | PMID:26833863 | Gpr85 | Rat | sunitinib | decreases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GPR85 mRNA | CTD | PMID:31533062 | Gpr85 | Rat | tetrachloromethane | affects expression | ISO | Gpr85 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GPR85 mRNA | CTD | PMID:17484886 | Gpr85 | Rat | titanium dioxide | decreases expression | ISO | Gpr85 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of GPR85 mRNA | CTD | PMID:29264374 | Gpr85 | Rat | titanium dioxide | multiple interactions | ISO | Gpr85 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR85 mRNA | CTD | PMID:29950665 | Gpr85 | Rat | trichostatin A | increases expression | ISO | GPR85 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GPR85 mRNA | CTD | PMID:24935251 | Gpr85 | Rat | triclosan | increases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Triclosan results in increased expression of GPR85 mRNA | CTD | PMID:30510588 | Gpr85 | Rat | tunicamycin | increases expression | ISO | Gpr85 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of GPR85 mRNA | CTD | PMID:17127020 | Gpr85 | Rat | valproic acid | affects expression | ISO | GPR85 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GPR85 mRNA | CTD | PMID:25979313 | Gpr85 | Rat | valproic acid | increases expression | ISO | GPR85 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GPR85 mRNA | CTD | PMID:23179753 more ... | Gpr85 | Rat | valproic acid | multiple interactions | ISO | GPR85 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR85 mRNA | CTD | PMID:27188386 | Gpr85 | Rat | vorinostat | increases expression | ISO | GPR85 (Homo sapiens) | 6480464 | vorinostat results in increased expression of GPR85 mRNA | CTD | PMID:27188386 | |